Atinary and Dr. Angelo Frei’s lab at the University of York secure funding to revolutionize metalloantibiotic discovery, leveraging AI and high-throughput screening to combat antimicrobial resistance.
MENLO PARK, California, and LAUSANNE, Switzerland – June 5, 2025 – Atinary Technologies is thrilled to announce the approval of an Alchemy fund, in collaboration with the lab of Dr. Angelo Frei, at the University of York, UK, for their project on AI-driven discovery of metal-based antibiotics (metalloantibiotics). AIchemy is a UK-based initiative supported by the Engineering and Physical Sciences Research Council. The hub is dedicated to transforming the intersection of chemistry and AI. This grant fosters collaboration between academia and industry, partnering Atinary’s AI expertise with the Frei lab’s strengths in metalloantibiotics. Together, they will accelerate the discovery of novel metal-based antimicrobials to combat the global antimicrobial resistance (AMR) crisis.
Read more about this collaboration on our website: full press release